Cleveland BioLabs News
BUFFALO, N.Y. -- Cleveland BioLabs, Inc. and Incuron, LLC, a joint venture between the Company and Bioprocess Capital Ventures, today announced the receipt of a Notice of Allowance from the U.S. Patent ...
Cleveland BioLabs' CEO Discusses Q1 2013 Results - Earnings Call Transcript
CORRECTION -- Cleveland BioLabs Reports First Quarter 2013 Financial Results and Development ProgressGlobeNewswire May 9
BUFFALO, N.Y. -- In a release issued earlier today under the same headline by Cleveland BioLabs, Inc. , the years in the column headers in the Consolidated Balance Sheets table were incorrect. With the ...
BUFFALO, N.Y. -- Cleveland BioLabs, Inc. today reported financial results and development progress for the first quarter ended March 31, 2013.
CLEVELAND BIOLABS INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or PrincMay 9
BUFFALO, N.Y. -- Cleveland BioLabs, Inc. today announced that its board of directors has appointed a shareholder representative, Randy S. Saluck, J.D., MBA as an independent director.
Isis Pharma announced the initiation of a phase Ib/IIa study on ISIS-STAT3